Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. is a distinguished clinical-stage drug development biopharmaceutical company dedicated to addressing liver, metabolic, and inflammatory diseases. Located at 16 Ze’ev Tiomkin Street, Tel Aviv, 6578317, IL, Galmed Pharmaceuticals Ltd. is focused on pioneering innovative treatments and improving patient outcomes.

With a commitment to advancing medical science, Galmed Pharmaceuticals Ltd. is at the forefront of developing novel therapeutic solutions. Their lead compound, Aramchol™, is a promising backbone drug candidate currently in a Phase 3 registrational study for the treatment of NASH and fibrosis. Additionally, Galmed Pharmaceuticals Ltd. collaborates with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide, further showcasing their dedication to cutting-edge research.

Galmed Pharmaceuticals Ltd. continues to push the boundaries of pharmaceutical innovation, driven by a vision of transforming patient care and addressing critical unmet medical needs. We invite the management team at Galmed Pharmaceuticals Ltd. to enhance your company's visibility by creating a customized and exclusive company showcase and product listing on our platform.